The Protein Inhibitor of Activated STAT 1 (PIAS1) is an E3 SUMO ligase that plays important roles 30 in various cellular pathways, including STAT signaling, p53 pathway, and the steroid hormone 31 signaling pathway. PIAS1 can SUMOylate PML (at Lys-65 and Lys-160) and PML-RARα promoting 32 their ubiquitin-mediated degradation. Increasing evidence shows that PIAS1 is overexpressed in 33 various human malignancies, including prostate and lung cancers. To understand the mechanism 34 of action of PIAS1, we developed a quantitative SUMO proteomic approach to identify potential 35 substrates of PIAS1 in a system-wide manner. Our analyses enabled the profiling of 983 SUMO 36 sites on 544 proteins, of which 204 SUMO sites on 123 proteins were identified as putative PIAS1 37 substrates. These substrates are involved in different cellular processes, such as transcriptional 38 regulation, DNA binding and cytoskeleton dynamics. Further functional studies on Vimentin 39 (VIM), a type III intermediate filament protein involved in cytoskeleton organization and cell 40 motility, revealed that PIAS1 exerts its effects on cell migration and cell invasion through the 41 SUMOylation of VIM at Lys-439 and Lys-445 residues. VIM SUMOylation was necessary for its 42 dynamic disassembly, and cells expressing a non-SUMOylatable VIM mutant showed reduced 43 levels of proliferation and migration. Our approach not only provides a novel strategy for the 44 identification of E3 SUMO ligase substrates, but also yields valuable biological insights into the 45 unsuspected role of PIAS1 and VIM SUMOylation on cell motility. 46 47 48
INTRODUCTION
PIAS SIM (SUMO interaction motif) recognizes SUMO moieties of modified substrates and alters 77 subnuclear targeting and/or assembly of transcription complex [16] [17] [18] . While several functions have 78 been attributed to these domains, relatively little is known about the role of the poorly conserved 79 C-terminus serine/threonine-rich region. 80 PIAS1 is one of the most well studied E3 SUMO ligases, and was initially reported as the 81 inhibitor of signal transducers and activators of transcription 1 (STAT1) 19 . Previous studies 82 indicated that PIAS1 interacts with activated STAT1 and suppresses its binding to DNA 8 . PIAS1 83 overexpression was reported in several cancers, including prostate cancer, multiple myeloma, 84 and B cell lymphomas [20] [21] [22] [23] . PIAS1 can SUMOylate the Focal adhesion kinase (FAK) at Lys-152, a 85 modification that dramatically increases its ability to autophosphorylate Thr-397, activate FAK, 86
and promotes the recruitment of several enzymes including Src family kinases 24 . In yeast, Lys-164 87
SUMOylation on Proliferating Cell Nuclear Antigen (PCNA) is strictly dependent on the PIAS1 88 ortholog Siz1, and is recruited to the anti-recombinogenic helicase Srs2 during S-phase 25 . PIAS1 89 can also regulate oncogenic signaling through the SUMOylation of promyelocytic leukemia (PML) 90 and its fusion product with the retinoic acid receptor alpha (PML-RARα) as observed in acute 91 promyelocytic leukemia (APL) 26 . In addition to its regulatory role in PML/ PML-RARα oncogenic 92 signaling, PIAS1 has been shown to be involved in the cancer therapeutic mechanism of arsenic 93 trioxide (ATO). This is accomplished by ATO promoting the hyper-SUMOylation of PML-RARα in 94 a PIAS1-dependent fashion, resulting in the ubiquitin-dependent proteasomal degradation of 95 PML-RARα and APL remission 26 . In B cell lymphoma, PIAS1 has been reported as a mediator in 96 lymphomagenesis through SUMOylation of MYC, a proto-oncogene transcription factor 97 associated with several cancers. SUMOylation of MYC leads to a longer half-life and therefore an 98 increase in oncogenic activity 23 . Altogether, these reports suggest that PIAS1 could promote 99 cancer cell growth and progression by regulating the SUMOylation level on a pool of different 100
substrates. 101
In this study, we first evaluate the effect of PIAS1 overexpression in HeLa cells. PIAS1 102 overexpression has a significant influence on cell proliferation, cell migration and cancer cell 103 invasion. To identify putative PIAS1 substrates, we developed a system level approach based on 104 quantitative SUMO proteomic analysis 27 to profile changes in protein SUMOylation in cells 105 overexpressing this E3 SUMO ligase. Our findings revealed that 204 SUMO sites on 123 proteins 106 were regulated by PIAS1. Bioinformatic analysis indicated that many PIAS1 substrates are 107 involved in transcription regulation pathways and cytoskeleton organization. Interestingly, 108 several PIAS1 substrates, including cytoskeletal proteins (Actin filaments, Intermediate filaments 109 and Microtubules), were SUMOylated at lysine residues located in non-consensus motif. We 110 confirmed the SUMOylation of several PIAS1 substrates using both in vitro and in vivo 111 SUMOylation assays. Further functional studies revealed that PIAS1 mediated the SUMOylation 112 of vimentin (VIM) at two conserved sites on its C-terminus that affect the dynamic disassembly 
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To investigate the physiological function of PIAS1 in HeLa cells, we overexpressed PIAS1 and 118 evaluated its expression level by western blot. The abundance of PIAS1 in HeLa cells was 119 increased by 2.5 fold at 48 h post-transfection ( Fig. 1a ). PIAS1 overexpression promotes HeLa cell 120 proliferation by ~50% ( Fig. 1b) . We further examined the phenotypic effects of PIAS1 121 overexpression on cell migration and cell invasion using wound-healing and Boyden chamber 122 invasion assays. The migration and invasion ability of Hela cells were both increased after PIAS1 123 overexpression (Figs. 1c-f). Taken together, these results highlight the role that PIAS1 plays in 124 regulating cell growth, cell cycle, cell migration and cell invasion of HeLa cells. 125 126
Identification of PIAS1 Regulated SUMOylation Sites by Quantitative Proteomics 127
To gain a better understanding of the role that PIAS1 plays in cell cycle regulation, cell 128 proliferation, invasion and motility, we devised a large-scale SUMO proteomic approach to 129 identify PIAS1 substrates in a site-specific manner (Fig. 2 ). We combined a SUMO remnant 130 immunoaffinity strategy 27 with metabolic labeling (stable isotope labeling of amino acid in cell 131 culture, SILAC) to study the global changes in protein SUMOylation upon PIAS1 overexpression. 132 HEK293 cells stably expressing SUMO3m ( Supplementary Fig. 1 ) were grown at 37 °C in media 133 containing light ( 0 Lys, 0 Arg), medium ( 4 Lys, 6 Arg), or heavy ( 8 Lys, 10 Arg) isotopic forms of lysine 134 and arginine. Three biological replicates were performed, and for each replicate, one SILAC 135 channel was transfected with an empty vector while the other two were transfected with Myc-136 PIAS1 vectors ( Fig. 2a ). At 48 h post-transfection, an equal amount of cells from each SILAC 137 channel were harvested and combined before lysis in a highly denaturant buffer. PIAS1 138 overexpression efficiency in HEK293 SUMO3m cells was evaluated by western blot (Fig. 2b) . 139
Protein extracts were first purified by Ni-NTA beads to enrich SUMO-modified proteins and 140 digested on beads with trypsin ( Fig. 2c ). Following tryptic digestion, SUMO-modified peptides 141 were immunopurified using an antibody directed against the NQTGG remnant that is revealed on 142 the SUMOylated lysine residue. Next, peptides were fractionated by offline strong cation 143 exchange (SCX) STAGE tips and analyzed by LC-MS/MS on a Tribrid Fusion instrument. To 144 determine that abundance changes were attributed to SUMOylation and not to change in protein 145 expression, we also performed quantitative proteomic analyses on the total cell extracts from 146 PIAS1 overexpression ( Fig. 3a and Supplementary Fig. 2 ). PIAS1 overexpression caused a global 147 increase in protein SUMOylation with negligible changes on protein abundance (Fig. 3b ). In total, 148 12080 peptides on 1756 proteins ( Fig. 3a , Supplementary Table 1 ) and 983 SUMO peptides on 149 544 SUMO proteins ( Fig. 3b , Supplementary Table 2 ) were quantified for the proteome and 150 SUMO proteome analyses, respectively. A total of 204 SUMOylation sites on 123 proteins were 151 found to be upregulated by PIAS1 overexpression including known substrates such as PCNA and 152 PML. A summary of these analyses is shown in Fig. 3 
c. 153
Protein classification ontology analysis of the PIAS1 substrates using PANTHER clustered the 154 targets into 15 groups (Fig. 3d ). PIAS1 mediated SUMOylation predominantly occurred on nucleic 155 acid binding proteins, transcription factors, cytoskeletal proteins, enzyme modulators, ligases 156 and chaperone proteins. We next classified putative PIAS1 substrates by their gene ontology (GO) 157 molecular function, biological process and cellular components ( Fig. 3e ) using the whole 158 identified SUMOylome as background. GO cellular component classification revealed that PIAS1 159 substrates were enriched in the plasma membrane and cytosol compared to the global 160 SUMOylome (Fig. 3e ). This suggests that PIAS1 substrates may undergo nucleocytosolic shuttling 161 upon SUMOylation. GO biological process analysis revealed that identified PIAS1 substrates are 162 involved in a variety of biological processes, such as protein stabilization, protein folding, histone 163 H3 acetylation, translational initiation, and signal recognition particle (SRP)-dependent co-164 translational protein targeting to membrane ( Fig. 3e ). GO molecular function analysis indicated 165 that PIAS1 substrates are associated with ubiquitin protein ligase binding, ubiquitin-protein 166 transferase activity and unfolded protein binding ( Fig. 3e ). Indeed, PIAS1 regulates the 167 SUMOylation of several proteins whose roles in the cell are diverse. Much like global 168
SUMOylation, PIAS1 mediated SUMOylation may play a role in several biological processes that 169 are independent from each other. 170
Previous SUMO proteome analyses indicated that under unstressed conditions, 171
approximately half of acceptor lysine residues are found in the SUMO consensus and reverse 172 consensus motifs 28 . Since it is believed that SUMOylation that occurs on the consensus motif 173 does not absolutely require an E3 ligase, we surmised that PIAS1 mediated SUMOylation may 174 occur at non-consensus motifs. We therefore compared the amino acid residues surrounding the 175 SUMOylation sites that are regulated by PIAS1 to those of the whole SUMO proteome 176 ( Supplementary Fig. 3a ). As anticipated, the sequences surrounding the PIAS1 mediated 177
SUMOylation sites are depleted in glutamic acid at position +2 and depleted of large hydrophobic 178 amino acids at position -1, consistent with the reduction of the consensus sequence. Indeed, E3 179 SUMO ligases appear to aid in the SUMOylation of lysine residues that reside in non-canonical 180
regions. Furthermore, we investigated the local secondary structures and solvent accessibility of 181 PIAS1 substrates surrounding SUMO sites using NetSurfP-1.1 software ( Supplementary Fig. 3b ). 182
We observed that one-third of PIAS1 regulated SUMOylation sites are located within α-helix and 183 approximately one-tenth within β-strand. In contrast, the majority of SUMOylated lysine residues 184 in the SUMO proteome are localized in coil regions. Taken together, these results support the 185 notion that PIAS1 mediated SUMOylation preferentially occurs on structured regions of the 186 protein, which may help substrate recognition by PIAS1. Additionally, we noted that PIAS1 187 mediated SUMOylation occurred primarily on solvent exposed lysine residues, which was also 188 the case for the global SUMOylome. These results suggest that PIAS1 may not impart 189 conformational changes to its substrate upon binding since it does not promote SUMOylation on 190 lysine residues that would otherwise be buried within the core of the substrate. Overall, PIAS1 191 promotes the ability of UBC9 to SUMOylate lysine residues that are present in non-consensus 192 sequences located on ordered structures of the proteins. 193
To better understand the cellular processes regulated by PIAS1, a STRING analysis was 194 performed to analyze the interaction network of putative PIAS1 substrates. This network 195 highlights the presence of highly connected interactors from promyelocytic leukemia protein 196 (PML) nuclear body, transcriptional factors, cytoskeletal proteins and RNA binding proteins ( Fig.  197 4). PIAS1 was previously shown to colocalize to PML nuclear body and to regulate oncogenic 198 signaling through SUMOylation of PML and its gene translocation product PML-RARα associated 199 with acute promyelocytic leukemia (APL) 26 . 200
Interestingly, we also found that several putative PIAS1 substrates were associated with 201 cytoskeletal organization including β-actin (ACTB), α-tubulin (TUBA1B), vimentin (VIM) and 202 Lamins B1 and B2) on their Rod domains ( Supplementary Fig. 6 ). 218 219
Validation of identified PIAS1 substrates by in vitro and in vivo SUMOylation assays 220
Next, we selected E3 SUMO-protein ligase NSE2 (NSMCE2), prefoldin subunit 2 (PFDN2) and 221 VIM, which were identified in SUMO proteomic experiments as putative PIAS1 substrates for 222 further validation. We performed both in vitro and in vivo SUMOylation assays to confirm that 223 these sites were regulated by PIAS1. For the in vitro SUMO assay, we incubated individual SUMO 224 substrates with SUMO-activating E1 enzyme (SAE1/SAE2), UBC9, SUMO-3 with or without PIAS1 225 in the presence of ATP. We also used PCNA, a known PIAS1 substrate, as a positive control. After 226 4h incubation at 37 °C, the western blots of each substrate showed either single or multiple bands 227 of higher molecular weight confirming the SUMOylated products. Separate LC-MS/MS 228 experiments performed on the tryptic digests of the in vitro reactions confirmed the 229 SUMOylation of NSMCE2 at residues Lys-90, Lys-107, and Lys-125, and PFDN2 at residues Lys-94, 230
Lys-111, Lys-132, and Lys-136. While UBC9 alone can SUMOylate these substrates, we noted an 231 increasing abundance of SUMOylated proteins when PIAS1 was present, confirming that the E3 232 SUMO ligase enhanced the efficiency of the conjugation reaction ( Figure S7a ). Interestingly, 233
several SUMOylation sites that were regulated by PIAS1 on both NSMCE2 and PFDN2 were not 234 located within SUMO consensus motifs, further supporting the motif analysis of the large-scale 235 proteomic data ( Supplementary Fig. 3a) . 236
Furthermore, we examined whether PIAS1 contributes to substrate SUMOylation in vivo. 237 HEK293-SUMO3 cells were co-transfected with Flag-NSMCE2, PFDN2 or VIM and Myc-PIAS1. Co-238 transfected cells were subjected to immunoprecipitation with anti-Flag agarose gel, followed by 239 western blot with an anti-His antibody. The SUMOylation of substrates was minimally detected 240 when only transfecting Flag-substrates. In contrast, overexpression of PIAS1 under the same 241 experimental conditions led to a marked increase in the SUMOylation of these substrates 242 ( Supplementary Fig. 7b ). These results further confirm our quantitative SUMO proteomics data 243 and validate the proteins NSMCE2, PFDN2 and VIM as bona fide PIAS1 substrates. 244
245
PIAS1 SUMOylation Promotes its Localization to PML-NBs 246
Interestingly, our large-scale SUMO proteomic analysis identified five SUMOylation sites on 247 PIAS1 ( Fig. 5a ). Two of these sites (Lys-46, Lys-56) are located in the SAP domain, and may 248 regulate the interaction of PIAS1 with DNA 15 . We also identified two SUMOylated residues (Lys-249 137 and Lys-238) located within the PINIT domain of PIAS1, potentially affecting its subcellular 250 localization 14 . The last SUMOylated site (Lys-315) of PIAS1 and is located next to an SP-RING 251 domain, which may alter the ligation activity of PIAS1 31 . Of note, PIAS1 contains a SUMO 252 interaction motif (SIM), and previous reports indicated that this ligase can localize to PML nuclear 253 bodies in a SIM-dependent manner with SUMOylated PML 32 . As PML also contains a SIM motif, 254 we were interested in three out of the five SUMO sites on PIAS1: Lys-137, Lys-238 and Lys-315. 255
Since PIAS1 is SUMOylated at several sites and PML contains a SIM, we surmised that reciprocal 256 interactions could be mediated through SUMO-SIM binding. Accordingly, we constructed a 257 PIAS1-GFP vector and used site-directed mutagenesis to specifically mutate the PIAS1 lysine 258 residues that are SUMO modified and are located within regions of PIAS1 that could interact with 259 PML. As the SAP domain of PIAS1 is exclusively reserved for DNA binding, we excluded the SUMO-260 modified lysine residues in this domain when creating the mutant construct as it may affect its 261 localization in a PML independent fashion. We therefore created the variant constructs by 262 mutating the codons for Lys-K137, Lys-238 and Lys-315 to arginine codons. Several mutant genes 263 were created, including single mutants of each site, double mutant combinations, and the triple 264 mutant (PIAS1-GFP 3xKR). These mutant vectors were transfected into HEK293 SUMO3m cells 265 and used to study the effects of SUMOylation at the various lysine residues on the PIAS1-PML 266 colocalization. As evidenced by the immunofluorescence studies, approximately 45% of WT 267 PIAS1-GFP colocalized with PML ( Fig. 5b ). No significant changes in the colocalization of PIAS1 268 and PML were observed when experiments were repeated using either single or double PIAS1-269 GFP mutants (data not shown). However, we noted a 50% reduction in PIAS1-GFP-PML 270 colocalization when all three sites were mutated, suggesting a possible functional redundancy 271 among these sites (Figs. 5b and 5c). The fact that the co-localization of PML and PIAS1-GFP was 272 not totally abrogated for the triple mutant might be explained by residual interactions between 273 SUMOylated PML and the SIM of PIAS1-GFP 32 . Taken together, these experiments confirmed that 274 colocalization of PIAS1 at PML nuclear bodies is partly mediated by the SUMOylation of PIAS1 at 275
Lys-137, Lys-238 and Lys-315 residues. 276
277
VIM SUMOylation Promotes Cell Proliferation and Motility and Increases VIF Solubility 278
VIM is predominantly found in various mesenchymal origins and epithelial cell lines [33] [34] [35] . 279
Increasing evidence shows that VIM plays key roles in cell proliferation 36 , migration 37 and 280 contractility 38 . Our data shows that two SUMO sites on VIM are regulated by PIAS1, both of which 281 are located on the tail domain and are highly conserved across different species (Fig. 6a ). To 282 further investigate the function of PIAS1 mediated SUMOylation of VIM, we expressed a Flag-283 tagged VIM K439/445R double mutant (VIM mt ) that is refractory to SUMOylation in HeLa cells, 284 and compared the functional effects to cell expressing the wild-type Flag-tagged VIM (VIM wt ). We 285 transfected Flag-VIM wt and Flag-VIM mt into HeLa cells and used the empty Flag vector as a 286 negative control. At 48 h post-transfection, the cells were harvested, lysed in 8 M urea and 287 protein pellets were separated on SDS-PAGE. The ensuing western blot results show that protein 288 abundance between VIM wt and VIM mt are similar; yet, the SUMO level on VIM mt is undetectable 289 ( Fig. 6b ). Growth assays demonstrate that VIM wt expression has no effect on HeLa cell 290 proliferation while VIM mt expression results in a significant inhibition of cell growth (Fig. 6c) . 291
Moreover, we examined the effect of VIM wt and VIM mt expression on cell migration and invasion 292 using wound-healing and Boyden chamber invasion assays. VIM wt significantly promotes cell 293 migration and invasion, which is in line with the results obtained in HepG2 cells 39 . However, 294
VIM mt conferred no effect on cell migration or invasion (Figs. 6d-g). These results indicate that 295
SUMOylation of VIM plays a role in cell growth, migration and invasion, presumably by regulating 296 VIM IF function and/or formation. 297
Next, we investigated the function of VIM SUMOylation on the dynamics assembly of IFs. Both 298
Keratin and lamin A IFs formation and solubility have been reported to be regulated by 299
SUMOylation, while such properties have yet to be uncovered for VIM IFs 40 . For example, the 300 SUMOylation of lamin A at Lys-201, which is found in the highly conserved rod domain of the 301 protein, results in its proper nuclear localization 41 . Unlike lamin A SUMOylation, keratin 302
SUMOylation is not detected under basal conditions. However, stress-induced keratin 303
SUMOylation has been observed in mouse and human in chronic liver injuries. Additionally, 304 keratin monoSUMOylation is believed to increase its solubility, while hyperSUMOylation 305 promotes its precipitation 42 . 306
We surmised that SUMOylation on VIM would alter its solubility, akin to the properties 307 observed for keratin. Accordingly, we transfected an empty vector as a negative control, VIM wt 308 and VIM mt into HeLa cells and lysed the cells with a RIPA buffer. Samples were fractionated into 309 RIPA soluble and insoluble fractions. Western blot analysis of these samples shows that VIM wt is 310 preferentially located in the RIPA soluble fraction, while VIM mt resides more in the insoluble 311 fraction ( Fig. 7a ). Clearly, SUMOylation of VIM drastically increases its solubility. Next, we sought to examine if VIM SUMOylation alters its phosphorylation status, which 322 could lead to changes in VIM IF dynamic assembly/disassembly. Accordingly, we separated 323 protein extracts from VIM wt and VIM mt by SDS-PAGE, excised bands that corresponded to the 324 soluble and insoluble VIM, and performed in-gel trypsin digestion followed by LC-MS/MS 325 ( Supplementary Fig. 8 ). We identified several phosphorylated serine residues and one 326 phosphorylated threonine residue on VIM ( Supplementary Table 3 ), which have also been 327 reported in the literature (S5, S7, T20, S22, S26, S29, S39, S42, S51, S56, S66, S72, S73, S83, S226, 328 T258 and S459). All sites except those located on the C-terminal were found to be 329 hyperphosphorylated in the insoluble VIM mt compared to the wild-type counterpart. 330
Interestingly, we observed an increase phosphorylation of S39 in the insoluble pellet of VIM mt , a 331 site known to be phosphorylated by Akt 41 . The observation that VIM is hyperphosphorylated at 332 its N-terminus in VIM mt suggests a possible cross-talk between SUMOylation and 333 phosphorylation. 334
To further understand how SUMOylation affects VIM dynamics in vivo, we transfected 335 Emerald-VIM wt or -VIM mt vectors in VIM null MCF-7 cells. VIM null cells were employed to 336 eliminate the contribution of endogenous VIM on the VIM dynamics, which could mask the 337 phenotypic effects of our mutant. Using fluorescence microscopy we quantified the proportion 338 of the various VIM structures for the two different Emerald tagged constructs. We found three 339 major forms of VIM in the cells, which in accordance with the literature, were categorized as 340 cytosolic, unit-length filament (ULF) and VIM intermediate filaments (VIFs) ( Supplementary Fig.  341   9) . Statistical analysis of the proportion of the VIM structures revealed that the SUMO 342 conjugation deficient VIM (VIM mt ) promoted the formation of ULF with a concomitant reduction 343 in VIF formation compared to its wild-type counterpart (Fig. 7b ). Taken together these results 344
indicate that SUMOylation of VIM promotes the formation of VIFs from the ULF building blocks. 345
Although VIM filament growth primarily relies on elongation by the longitudinal annealing of 346
ULFs via end-to-end fusion, recent studies suggest that the subunit exchange of tetramers within 347 these filaments does occur 48 . To determine if the SUMOylation of VIM affects the subunit 348 exchange rate of these filaments we performed fluorescence recovery after photobleaching 349 (FRAP) assays ( Supplementary Fig. 10 ). We monitored the recovery time of filament fluorescence 350 up to 300 s after bleaching for both Emerald-VIM wt and Emerald-VIM mt , and noted no statistical 351 difference in recovery between constructs (Fig. 7c ). This observation suggests that the 352 SUMOylation of VIM is not involved in the subunit exchange of tetramers within filaments. 353
The model described in Fig. 7d combines the results from the proteomic, 354 immunofluorescence and FRAP assays and describes the molecular mechanism of PIAS1 355 mediated control of VIM dynamics. Under physiological conditions, vimentin is maintained in 356 equilibrium between ULF and soluble tetramers. The formation of VIM ULF has been shown to 357 occur spontaneously on the order of seconds in vitro showing that this arrangement is 358 thermodynamically favorable and proceeds rapidly without the need for protein modifications 49 . 359
Vimentin filaments elongate by end-to-end annealing of ULFs and eventually form mature 360 vimentin intermediate filaments (VIFs). This is followed by the breakdown of VIFs by severing, 361 which involves phosphorylation on several residues found on the N-term of VIM 47,50 . We show in 362 this work that this hyper-phosphorylation occurs exclusively on the N-terminal of VIM in a SUMO-363 dependent mechanism. The truncated filaments can reanneal with another ULF to form larger 364
VIFs. However, the phosphorylated ULF must be SUMOylated by PIAS1 to increase either the 365 solubility or interaction with protein phosphatases, such as type-1 (PP1) and type-2A (PP2A) 366 protein phosphatases, as shown by the large increase in vimentin phosphorylation levels with 367 the SUMO deficient vimentin construct. 47 These results suggest that the PIAS1-mediated 368
SUMOylation of VIM stimulates the dephosphorylation of ULF and facilitate the reentry of the 369 ULF into the VIF maturation process by annealing on growing VIFs. This dynamic assembly and 370 disassembly of VIFs thus involve the SUMOylation of VIM, a modification that also regulates the 371 cell proliferation, migration and invasion (Fig. 6) . 372
373
DISCUSSION 374
We report the functional effect of E3 SUMO ligase PIAS1 in HeLa cells, and determined that 375 PIAS1 not only promotes cell proliferation, but also stimulates cell migration and invasion. PIAS1 376 has been extensively studied in other cancer lines, such as Human Prostate Cancer, where PIAS1 377 expression is increased and enhanced proliferation through inhibition of p21 21 . In addition, other 378 studies have also reported that PIAS1 may function as a tumor suppressor to regulate gastric 379 cancer cell metastasis by targeting the MAPK signaling pathway 51 . IL-11 mediated decrease in 380 HTR-8/SVneo cells invasiveness was associated with a decrease in ERK1/2 activation, PIAS1/3-381 mediated activated STAT3 (Tyr-705) sequestration, and a decrease in PIAS1 expression, leading 382 to a decrease in the expression of Fos and major families of metalloproteinase (MMP2, MMP3, 383 MMP9 and MMP23B) 52 . However, these studies were limited to individual PIAS1 targets to 384 understand the regulation mechanism. These targeted approaches sufficed to answer specific 385 questions about PIAS1 mediated SUMOylation, but lack the depth to fully elucidate the function 386 of PIAS1. A systematic approach to establish the global properties of PIAS1 as an E3 SUMO ligase 387 and how these SUMOylation events alter substrate function are missing and needed. Indeed, 388 such a method was never conceived due to the complex nature of quantitative SUMO 389 proteomics. Global SUMO proteome analyses are challenging due to the low abundance of 390 protein SUMOylation and the extremely large remnant that is retained on the modified lysine 391 residues upon tryptic digestion. Moreover, proteomic workflows that are currently available to 392 study SUMOylation require two levels of enrichment, which adversely affects the reproducibility 393 of SUMO site quantitation. 394
We devised an efficient method for the identification PIAS1 substrates by modifying our 395 previously described SUMO proteomics approach 27 . This method combines SILAC labelling for 396 reproducible quantitative proteomic analyses, E3 SUMO ligase protein overexpression, followed 397 by SUMO remnant immunoaffinity enrichment. This workflow allows for the selective profiling 398 of substrates and regulated SUMOylation sites of any E3 SUMO ligase. All the PIAS1 substrates 399 identified in this work were analyzed using forward and reverse SILAC labeling under basal 400 condition, which further increases the confidence of the identified substrates. Notably, we 401 observed that PIAS1 overexpression has a global effect on protein SUMOylation (Fig. 3b ). This is 402 in part due to some PIAS1 substrates being directly involved in protein SUMOylation, such as 403 PIAS2, PIAS3, NSMCE2, TOPORS and TRIM28. In addition, many of the identified substrates were 404 found to participate in protein ubiquitination regulation, such as TRIM24, TRIM33, RNF2 and 405 BRCA1, which may also affect the global protein SUMOylation through the interplay between 406
SUMOylation and ubiquitination 27, 53 . 407
We identified five SUMOylation sites on PIAS1 itself (Lys-46, Lys-56, Lys-137, Lys-238 and Lys-408 315), suggesting a possible feedback mechanism that could keep SUMOylation levels in check. 409
Our immunofluorescence studies show that SUMOylation of PIAS1 promotes its localization to 410 PML nuclear bodies ( Figs. 5c and 5d ). Interestingly, a recent paper that studied the substrates of 411 RNF4 identified PIAS1 as a substrate of this SUMO-targeted ubiquitin ligase 54 . Moreover, RNF4 is 412 localized to PML nuclear bodies, where it ubiquitylates SUMOylated proteins for their 413 subsequent proteasomal degradation. Elevated levels of cellular SUMOylation may lead to an 414 increase SUMOylation of PIAS1, prompting its localization to PML nuclear bodies and its 415 degradation by RNF4 in a ubiquitin-dependent manner. This feedback mechanism used to 416 regulate global SUMOylation may not be reserved solely for PIAS1. Indeed, other members of the 417 PIAS family, as well as NSE2 and TOPORS, have been found to be SUMOylated at several lysine 418 residues, while also being substrates of RNF4 54 . 419
Notably, cytoskeletal proteins occupy a significant proportion of the identified PIAS1 420
substrates. Constituents of actin filaments, intermediate filaments and microtubules were all 421
found to be PIAS1 substrates. Interestingly, unlike UBC9 substrates that are typically SUMOylated 422 on consensus motifs 6 , the acceptor lysine residues found on these cytoskeletal proteins are highly 423 conserved but are located in non-consensus sequence motif. These observations suggest that 424 PIAS1 may act as an adaptor protein to change cytoskeletal protein turnover or dynamics by 425 facilitating their SUMOylation. We uncovered that SUMOylation on the tail domain of VIM 426 increases its solubility and promotes the uptake of ULF onto VIF in a phospho-dependent 427 mechanism. The dynamic VIF disassembly/reassembly that is promoted by VIM SUMOylation in 428 turn favors cell motility and invasion, which could lead to an increase in cancer cell aggressiveness. 429
Although these findings could reveal the molecular mechanism of PIAS1 mediated VIM 430
SUMOylation and its involvement in cancer cell aggressiveness, additional evidence is required 431 to further understand the function of PIAS1-mediated SUMOylation on the other cytoskeletal 432 proteins and how these cytoskeletal proteins collaborate during cell migration. 
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Cells were collected 48 h after transfection and protein overexpression was confirmed by western blot.
567
Cell Proliferation Assay
568
The cell proliferation assay was carried out using WST-1 Cell Proliferation Assay Kit (Roche). Transfected 569 cells were seeded into 96-well plates at a density of 1 × 10 3 cells/well. After 0, 2 and 4 days of incubation,
570
WST-1 reagents were added to each well, and cells were further incubated at 37 °C for 1 h. Each 
592
Then cells were incubated with 10% acetic acid to elute the dye and the relative cell numbers were 593 estimated using the absorbance optical density (OD) at 590 nm. 
594
SILAC Labeling and Protein Extraction
714
We automatically detected and assessed the number of PIAS1 and PML positive structures by using the 715 "particle analysis" tool from ImageJ. We then calculated the ratio manually.
716
In-gel Digestion and LC-MS/MS Identification
717
Cell pellets were resuspended in 5 pellet volumes of ice cold RIPA buffer. The lysate was spun at 13 000 g 718 for 10 minutes to separate the extract into RIPA soluble and insoluble fractions. The soluble and insoluble VIM samples were separated on a 4-12% SDS-PAGE (Bio-rad), and the proteins were visualized by 720 coomassie staining. The gel lane around vimentin corresponding position (57 kDa) was cut and then diced 721 into ∼1 mm 3 cubes. During the process of in-gel digestion, the gel pieces were first destained completely 722 using destaining solution (50% H2O, 40% methanol, and 10% acetic acid). Then the gel pieces were 723 dehydrated by washing several times in 50% acetonitrile (ACN) until the gel pieces shriveled and looked 724 completely white. The proteins were reduced in 10 mM DTT at 56 o C for 30 min, alkylated in 55 mM 725 iodoacetamide at room temperature (RT) in the dark for 30 min, and digested overnight with 300 ng of 726 sequencing grade modified trypsin in 50 mM ammonium bicarbonate . The supernatants were transferred 727 into Eppendorf tubes, and the gel pieces were sonicated twice in extraction buffer (67% ACN and 2.5% 728 trifluoroacetic acid). Finally, the peptide extraction and the initial digest solution supernatant were 729 combined and then dried using a Speed Vac. Peptides were reconstituted in water containing 0.2% formic 730 acid and analyzed by nanoflow-LC-MS/MS using an Orbitrap Q Exactive HF Mass spectrometer (Thermo 731 Fisher Scientific) as described previously 66 .
732
Fluorescence Recovery After Photobleaching (FRAP) assay 733
The FRAP assays were conducted on a LSM 880 confocal microscope equipped with a thermostatized 734 chamber at 37 °C. The Vimentin Emerald expressing cells were detected using a GaAsp detector. Bleaching 735 was done by combining "Time", "Bleach" and "Region" modes on Zen software from Zeiss. Briefly, 5 pre-736 bleach images were taken every 5 seconds, after which five pulses of a 488 nm laser were applied to 737 bleach an area of 25 × 2 μm. Post-bleach images were acquired every 5 seconds for 5 minutes. For 738 fluorescence recovery analysis, the intensity in the bleached region was measured varying time points 739 with "Frap profiler" plugin in ImageJ software. Bleach data were normalized to unbleached regions for all 740 the time points and expressed in arbitrary units in the recovery graphs.
741
Quantification of Vimentin organization.
742
Fixed images of cells expressing Emerald-VIM wt or Emerald-VIM mt were taken using a LSM 880 confocal 743 microscope. The "title" mode in the Zen software from Zeiss was used to cover a large area of cells
744
(2,13mm x 2,13mm). To avoid localization and conformation artefacts due to expression levels, only the 745 cells expressing Emerald-Vimentin at an intermediate level were evaluated using the threshold module in 746 ImageJ. The same manual threshold was used for all conditions. Cells were tabulated using the "Cell 747 counter" plugin in ImageJ into 4 categories: ULF, VIFs, cytosolic and total cells. Categories specification were performed manually and subjectively. A representative image of each category is shown in Figure   749 S9. More than 250 cells were counted for each experiments (N=3, n total cells = 750).
751
Statistical Analysis
752
Statistical analysis was carried out to assess differences between experimental groups. Statistical 753 significance was analyzed by the Student's t-tests. p<0.05 was considered to be statistically significant.
754
One asterisk and two asterisks indicate p<0.05 and p <0.01, respectively. 755 756
